News - Page 38 - Psychedelic Alpha

Our 🎯 Q1 2026 Psychedelic Pipeline Bullseye Charts are now available.

Read more about the article Clearmind Medicine Closes US$2.25 Million Public Offering

Clearmind Medicine Closes US$2.25 Million Public Offering

Post published:September 18, 2023
Post category:Press Release

Read more about the article Reunion Neuroscience Inc. Announces FDA Clearance of IND Application to Initiate a Phase 2 Study of RE104 for the Treatment of Postpartum Depression

Reunion Neuroscience Inc. Announces FDA Clearance of IND Application to Initiate a Phase 2 Study of RE104 for the Treatment of Postpartum Depression

Post published:September 18, 2023
Post category:Press Release

Read more about the article Optimi Health Celebrates Encouraging Results from the MAPS Phase 3 MDMA-Assisted Therapy Clinical Trial

Optimi Health Celebrates Encouraging Results from the MAPS Phase 3 MDMA-Assisted Therapy Clinical Trial

Post published:September 14, 2023
Post category:Press Release

Read more about the article Clearmind Medicine Announces Pricing of US$2.25 Million Public Offering

Clearmind Medicine Announces Pricing of US$2.25 Million Public Offering

Post published:September 14, 2023
Post category:Press Release

Read more about the article Second Phase 3 Study of MDMA-assisted Therapy Reports Positive Results, Paving Way for New Drug Application

Second Phase 3 Study of MDMA-assisted Therapy Reports Positive Results, Paving Way for New Drug Application

Post published:September 14, 2023
Post category:News

Read more about the article BetterLife Pharma to Host Investors Update Call on September 18, 2023

BetterLife Pharma to Host Investors Update Call on September 18, 2023

Post published:September 14, 2023
Post category:Press Release

Read more about the article atai Life Sciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference

atai Life Sciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference

Post published:September 14, 2023
Post category:Press Release

Read more about the article Does Humanity’s Fate Lie in the Hands of the Fungal Kingdom?

Does Humanity’s Fate Lie in the Hands of the Fungal Kingdom?

Post published:September 13, 2023
Post category:Opinions

Read more about the article Silo Pharma Initiates Feasibility Study of SPC-15 Novel Intranasal Formulation for PTSD

Silo Pharma Initiates Feasibility Study of SPC-15 Novel Intranasal Formulation for PTSD

Post published:September 12, 2023
Post category:Press Release

Read more about the article BetterLife Obtains Favourable Animal Safety Data for Repeated Oral Dosing of BETR-001

BetterLife Obtains Favourable Animal Safety Data for Repeated Oral Dosing of BETR-001

Post published:September 12, 2023
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond. Psy Alpha Ltd is a company registered in England and Wales (16989109).

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.